Covered Medications
The Department of Defense’s (DoD) policy on generic drugs requires the pharmacy to substitute generic medications for brand-name medications when a generic equivalent is available. Brand-name drugs with a generic equivalent may be given only if your physician submits a brand name prior authorization request and approval is granted by Johns Hopkins US Family Health Plan (USFP). In those cases, you will pay the brand name copayment. If the requested drug also requires prior authorization, your doctor should submit a prior authorization request as well. If you insist on having a prescription filled with a brand name drug when a generic equivalent is available, and medical necessity for your use of the brand name drug has not been established, you will be responsible for the entire cost of the prescription.
Although generic drugs are chemically identical to their branded counterparts and are held to the same FDA standards for safety and performance as brand-name drugs, they sell for 30-75 percent less. You can save money on your co-payment by choosing generic drugs when applicable. Additional information on generic drugs is available on the FDA website.
Other covered medications
Our pharmacy program provides outpatient coverage to members for medications that are approved for marketing by the U.S. Food and Drug Administration (FDA) and that generally require prescriptions. Other covered medications include:
- Compounded medications of which at least one ingredient is a legend drug
- Insulin
- Insulin syringes and needles
- Glucose test strips – FreeStyle Lite® and Precision Xtra® strips are TRICARE preferred test strips. All other test strips will require prior authorization.
- Lancets
You can find coverage and cost share details for specific drugs in the TRICARE formulary search tool.
* Freestyle Lite & Precision Xtra strips are TRICARE preferred test strips, all other test strips will require prior authorization.
Specialty Medications
Specialty medications are used to treat complex, long-term conditions. These are medications that may need special storage or have side effects that your health care provider needs to monitor. Some of these medications are covered by your pharmacy benefits and some are covered by your medical benefits.
Specialty medications covered by your pharmacy benefit are available at a local pharmacy. You take these medications on your own. For some of them, your provider may have to ask Johns Hopkins USFHP to approve them. Search the TRICARE Formulary for the specialty medications covered under the pharmacy benefit.
Some medications may only be available through certain specialty pharmacies. You may search the Pharmacy Benefit – Specialty Pharmacy location list for these medications and the pharmacies that can dispense them.
Specialty medications covered under your medical benefit are either given to you by your provider or taken while your provider is there with you. Some of these medical drugs may require prior authorization and your provider may have to ask Johns Hopkins USFHP to approve them.
Your doctor may find a list of medical drugs that have this prior authorization requirement and more information about how to submit a prior authorization request by visiting hopkinshealthplans.org.
Excluded medications include:
- Drugs prescribed for cosmetic purposes
- Fluoride preparations
- Food supplements
- Homeopathic and herbal preparations
- Multivitamins
- Over-the-counter products (except insulin, diabetic supplies, and select OTC products)
Drug Class | Products not covered/removed from TRICARE Formulary | Formulary Alternatives | Effective Date of Change |
---|---|---|---|
TIBs | adalimumab (Cordavis brand of Humira) |
|
11/13/2024 |
Acne Agents: Topical Acne and Rosacea | clindamycin 1.2%, adapalene 0.15%, and benzoyl peroxide 3.1% topical gel (Cabtreo) |
|
08/28/2024 |
Pain Agents: NSAIDs | oxaprozin 300 mg capsules (Coxanto) |
|
08/28/2024 |
Cardiovascular Agents Miscellaneous | colchicine low dose (LODOCO 0.5 mg tablets |
|
06/12/2024 |
PAH: PDE-5 inhibitors | sildenafil 10 mg/mL oral suspension (Liqrev) |
|
02/28/2024 |
Binders Chelators Antidotes |
trientine tetrahydrochloride tabs (Cuvrior) |
|
02/28/2024 |
Sleep Disorders: Insomnia Agents | zolpidem 7.5 mg caps |
|
02/28/2024 |
Ophthalmic Dry Eye Agents |
loteprednol etabonate 0.25% ophthalmic suspension (Eysuvis) |
|
11/22/2023 |
Diuretics | furosemide SC injection (Fuoscix) |
|
08/30/2023 |
Benign Prostatic Hyperplasia Agents; 5-alpha Reductase Inhibitors | finasteride/ tadalafil (Entadfi) |
|
05/31/2023 |
Nasal Allergy Agents: Corticosteroids | olopatadine 665 mcg /mometasone 25 mcg nasal spray (Ryaltris Nasal Spray) |
|
05/31/2023 |
Skeletal Muscle Relaxants | baclofen oral solution (Lyvispah) |
|
03/01/2023 |
Acne Agents: Topical Acne & Rosacea | benzoyl peroxide 5% cream (Epsolay) |
|
03/01/2023 |
Nephrology Agents Miscellaneous | budesonide (Tarpeyo) |
|
11/30/2022 |
Narcotic Analgesics and Combinations | celecoxib/tramadol (Seglentis) |
|
11/30/2022 |
Anticholinergics-Antispasmodics | glycopyrrolate (Dartisla ODT) |
|
11/30/2022 |
Endocrine Agents Miscellaneous | levoketoconazole(Recorlev) |
|
11/30/2022 |
Diuretics | torsemide (Soaanz) |
|
11/30/2022 |
Acne Agents: Topical Acne & Rosacea | tretinoin 0.1%/benzoyl peroxide3% topical cream(Twyneo) |
|
11/30/2022 |
Pain Agents: NSAIDs | Celecoxib oral solution (Elyxyb) |
|
08/24/2022 |
Antianxiety Agents: Benzodiazepines | Lorazepam ER capsule (Loreev XR) |
|
06/15/2022 |
Migraine Agents | Dihydroergotamine mesylate nasal spray (Trudhesa) |
|
06/15/2022 |
Antilipidemic-1s | Rosuvastatin/ ezetimibe (Roszet) |
|
06/15/2022 |
Anticonvulsants-Antimania Agents | Levetiracetam (Elepsia XR) |
|
06/15/2022 |
Corticosteroids-Immune Modulators: High Potency | Clobetasol propionate 0.05% lotion metered dose pump (Impeklo) |
|
06/15/2022 |
Psoriasis Agents | Calcipotriene/ betamethasone dipropionate 0.005% /0.064% topical cream (Wynzora) |
|
06/15/2022 |
GI-1 Agents | Budesonide ER 9 mg capsules (Ortikos) |
|
06/02/2021 |
Corticosteroids | Dexamethasone 20 mg tables (Hemady) |
|
06/02/2021 |
Pulmonary I Agents Inhaled Corticosteroids (ICS) | Fluticasone propionate dry powder inhaler oral (ArmonAir Digihaler) |
|
06/02/2021 |
Pulmonary I Agents ICS/Long-Acting Beta Agonists (LABA) | Fluticasone propionate / salmeterol dry powder inhaler oral (AirDuo Digihaler) |
|
06/02/2021 |
Calcium Channel Blockers | Levamlodipine (Conjupri) |
|
06/02/2021 |
GI-2 Agents | Metoclopramide nasal spray (Gimoti) |
|
06/02/2021 |
Topical Psoriasis Agents | Calcipotriene 0.005% Betamethasone 0.064% Suspension (Taclonex, Generic) | Scalp Psoriasis:
Psoriasis involving areas other than the scalp:
|
2/24/2021 |
High-Potency Topical Corticosteroids | Halcinonide 0.1% topical solution (Halog) |
|
2/24/2021 |
Acne Agents:Topical Acne and Rosacea | Tazarotene 0.045% lotion (Arazlo) |
|
2/24/2021 |
Pain Agents Class; NSAIDs Subclass |
Consensi (Amlodipine-celecoxib) |
|
8/26/2020 |
Pain Agents Class; NSAIDs Subclass |
|
NSAIDs: celecoxib, diclofenac, indomethacin, meloxicam, naproxen, (also includes other NSAIDs) | 8/26/2020 |
Pain Agents Class; NSAIDs Subclass |
Duexis tablets (ibuprofen-famotidine) |
|
8/26/2020 |
Pain Agents Class; Pain Topical Subclass |
|
|
8/26/2020 |
Pain Agents Class; Pain Topical Subclass |
ZTlido (lidocaine 1.8% patch) | Lidocaine 5% patch | 8/26/2020 |
Pulmonary: Short Acting Beta-2 Agonists (SABA) | ProAir Digihaler (albuterol dry powder inhaler) |
|
8/26/2020 |
Acne Agents: Topical Acne and Rosacea | Enzoclear (benzoyl peroxide 9.8% foam) |
|
8/26/2020 |
Anti-Infectives: Miscellaneous | Talicia (omeprazole magnesium-amoxicillin-rifabutin) |
|
8/26/2020 |
Rapid Acting Insulins | Insulin plus niacinamide (Fiasp) |
|
07/01/2020 |
Pulmonary-2 Agents: COPD | Formoterol/aclidinium (Duaklir Pressair) |
|
06/10/2020 |
Migraine Agents: Triptans | Sumatriptan nasal spray (Tosymra) |
|
06/10/2020 |
GI2 Agents: CIC and IBS-C | Tegaserod (Zelnorm) |
|
06/10/2020 |
PDE-5 inhibitor |
|
|
06/03/2020 |
ADHD | Methylphenidate ER sprinkle capsules (Adhansia XR) |
|
03/04/2020 |
High-Potency Topical Corticosteroids |
|
|
03/04/2020 |
High-Potency Topical Corticosteroids | Halcinonide 0.1% ointment (Halog) |
|
03/04/2020 |
High-Potency Topical Corticosteroids |
|
|
03/04/2020 |
PPIs |
|
|
11/28/2019 |
High-Potency Topical Corticosteroids | Halobetasol propionate 0.05% foam (Lexette brand) |
|
10/01/2019 |
Diabetes Non- Insulin Drugs – Biguanides Subclass | Metformin ER gastric retention 24 hours (Glumetza) |
|
10/01/2019 |
Pain Agents – Combinations | Naproxen / Esomeprazole (Vimovo) |
|
10/01/2019 |